SCN9A and cancer: NaV1.7 was found to be overexpressed, in mRNA and in proteins, in prostate cancer biopsies compared to non-cancer prostate tissues, and it was even proposed to serve as a diagnosis marker for prostate cancer (Diss et al., 2005).